Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAMSCA vs SAXAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAMSCA vs SAXAGLIPTIN: Safety Overview

Metric SAMSCA SAXAGLIPTIN
Total FAERS Reports 236 2,468
Deaths Reported 53 263
Death Rate 22.5% 10.7%
Hospitalizations 34 838
Average Patient Age 69.1 yrs 65.5 yrs
% Female Patients 50.4% 47.8%
FDA Approval Date N/A Jul 31, 2009
Manufacturer N/A Glenmark Pharmaceuticals Inc., USA
Route N/A ORAL
Marketing Status N/A Discontinued